Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2003
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/04/2003US6642433 Nucleic acid construct comprising a promoter, marker and nucleotide sequence; producing animals with decreased gene expression and increased survival when infected with hepatitis virus; allograph rejection, fetal loss inflammatory bowel
11/04/2003US6642371 Haemophilus adherence and penetration proteins
11/04/2003US6642369 Nucleic acids involved in the responder phenotype and applications thereof
11/04/2003US6642362 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
11/04/2003US6642359 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease
11/04/2003US6642358 Receptor that binds trail
11/04/2003US6642356 Of given amino acid sequence; non-immunogenic; Fab fragment coupled to effector or reporter molecules; generates dimers which are resistant to chemical reduction
11/04/2003US6642354 Molecular mimetics of unique Neisseria meningitidis serogroup B epitopes
11/04/2003US6642062 Multihued labels
11/04/2003US6642040 Human cGMP-stimulated cyclic nucleotide phosphodiesterase
11/04/2003US6642038 GlcNAc phosphotransferase of the lysosomal targeting pathway
11/04/2003US6642032 Uses of avian interferon gamma (IFN-γ)
11/04/2003US6642025 Chlamydia antigens and corresponding DNA fragments and uses thereof
11/04/2003US6642023 High molecular weight; encoded by isolated nucleic acid; expression vectors; use for diagnostics, prophylaxis and treatment of infections
11/04/2003US6642018 Method for inducing a response in one or more targeted cells
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6642007 Assays for measurement of type II collagen fragments in urine
11/04/2003US6641999 Probing method for identifying antibodies specific for selected antigens
11/04/2003US6641815 Sequestrin
11/04/2003US6641812 Heat shock protein-based vaccines and immunotherapies
11/04/2003US6641809 Method of regulating cellular processes mediated by B7 and CD28
11/04/2003CA2097920C Site-specific conjugation of immunoglobulins and detectable labels
11/04/2003CA2085191C Vaccines based on modified type 1 bovine herpesviruses
11/04/2003CA2084677C Apo ai polypeptides, antibodies, and immunoassays
11/04/2003CA2073616C Use of hpv-16 e6 and e7-gene derived peptides for the diagnostic purpose
11/04/2003CA2071811C Improved meningococcal polysaccharide conjugate vaccine
11/01/2003CA2426589A1 Psp94 diagnostic reagents and assays
11/01/2003CA2391438A1 Psp94 diagnostic reagents and assays
11/01/2003CA2380662A1 Psp94 diagnostic reagents and assays
10/2003
10/30/2003WO2003089934A2 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1/lap-1
10/30/2003WO2003089928A1 Test for measurement of therapeutic drug levels
10/30/2003WO2003089902A2 Displacement assay for detection of small molecules
10/30/2003WO2003089651A2 Assay for quantitating secreted antibodies in lymphocytes supernatant
10/30/2003WO2003089630A1 Methods for producing immortalised antibodies-secreting cells
10/30/2003WO2003089624A2 Fc receptor homolog, reagents, and uses thereof
10/30/2003WO2003089620A2 Phospholipases, nucleic acids encoding them and methods for making and using them
10/30/2003WO2003089614A2 Production of functional antibodies in filamentous fungi
10/30/2003WO2003089611A2 ANTIBODIES FOR ENZYMES OF THE ω-OXIDATION PATHWAY AND METHODS RELATING THERETO
10/30/2003WO2003089607A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003WO2003089603A2 Cytokine receptor
10/30/2003WO2003089583A2 Tissue specific genes and gene clusters
10/30/2003WO2003089575A2 Antibodies that specifically bind to tl5
10/30/2003WO2003089475A2 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
10/30/2003WO2003089474A1 Dna dependent protein kinase catalytic subunit phosphorylation sites and antibodies thereto
10/30/2003WO2003089473A1 Vaccine composition for preventing meningococcal disease
10/30/2003WO2003089472A2 Anti-nls scfv and peptides and uses thereof in nuclear import inhibition
10/30/2003WO2003089471A1 Method for producing monoclonal antibodies
10/30/2003WO2003089451A2 Antibodies specific for mucin polypeptide
10/30/2003WO2003089450A2 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003WO2003089000A2 Anti-hiv composition, production method thereof and medicament
10/30/2003WO2003088999A1 Process for producing immunogloblin preparation
10/30/2003WO2003088998A1 Antibody combination useful for tumor therapy
10/30/2003WO2003088995A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003WO2003088979A2 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof
10/30/2003WO2003088911A2 Universal libraries for immunoglobulins
10/30/2003WO2003088898A2 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003WO2003088808A2 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003WO2003057919A3 The use of histamine h4 receptor antagonist for the treatment of inflammatory response
10/30/2003WO2003057837A8 Methods for using anti-muc18 antibodies
10/30/2003WO2003047421A3 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003WO2003046004A3 Macroglobulin biopolymer markers indicative of insulin resistance
10/30/2003WO2003039491A8 Novel isoforms of vascular endothelial cell growth inhibitor
10/30/2003WO2003039467A3 Monoclonal antibodies specific for beta-amyloid.
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003027143A3 Gene and protein relating to hepatocellular carcinoma
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003000717A3 Identification of ses-3 (spr-5) in c. elegans and the uses of the same
10/30/2003WO2002103362A3 Cancer associated protein
10/30/2003WO2002102229A3 Diagnosing tumorigenicity and determining resistance to anticancer therapy
10/30/2003WO2002098370A3 Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002094876A3 Methods and compositions for treating respiratory mucin production associated disease conditions
10/30/2003WO2002093519A3 Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
10/30/2003WO2002092634A3 Specific antibodies for histamine receptor subclasses
10/30/2003WO2002084294A3 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/30/2003WO2002071060A3 Use of metabolic phenotyping in individualized treatment with amonafide
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002062833A3 Modified leptin with reduced immunogenicity
10/30/2003WO2002059607A3 Isolation of epidermal stem cells by using the melanoma-associated chondroitin sulfate proteoglycan
10/30/2003WO2002059327A3 Sulfatases and methods of use thereof
10/30/2003WO2002059283A3 Nucleic acid modification enzymes
10/30/2003WO2002050280A3 Equine ige allotype
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003US20030204863 Nav2 channel gene-deficient non-human animals
10/30/2003US20030204097 For inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease
10/30/2003US20030204074 Streptococcus pneumoniae 37-kDa surface adhesin a protein
10/30/2003US20030204072 Comprises receptor protein tyrosine kinase (rPTK) for diagnosing and treating kidney or neurodegenerative diseases
10/30/2003US20030204071 109 human secreted proteins
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204066 Using to anticytokine to treat rheumatic diseases; immunotherapy; immunoassay
10/30/2003US20030204065 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders
10/30/2003US20030204062 Immunoglobulin specific for osteoclast hydrolase (TRACP5AL) for use in the diagnosis and treatment of bone disorders
10/30/2003US20030204059 Preparing cytotoxic lymphocyte maturation factor (CLMF) from genetically engineered lymphoblastoid cells; for treating and preventing tumors and inflammation
10/30/2003US20030204055 Comprise nucleotide sequences coding polypeptide for treating and preventing inflammation, tumors and nervous system disorders; animal models; gene therapy
10/30/2003US20030204053 Comprise nucleotide sequences coding polypeptide for treating and preventing inflammation, tumors and nervous system disorders; animal models; gene therapy
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030203840 Nucleic acid containing at least one adenine base, a guanine base, a cytosine base, and at least thymin or uracil base and nucleic acid is atleast 12 bases in length, hybridizes to sense or antisense strand of second nucleic acid
1 ... 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 ... 1494